Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2021 ∙ SAGE

Considerations for pneumococcal vaccination in older adults

  • SAGE background document
  • Pneumococcal disease
Download:
2021 ∙ SAGE

Pneumococcal vaccines: WHO position paper on their use in community outbreak settings

  • Position paper
  • Pneumococcal disease
Download:
2021 ∙ Conseil Supérieur de la Santé (CSS)

Recommendations for the vaccination of children at increased risk of invasive pneumococcal disease (PID)

  • Recommendation
  • Europe
  • Belgium
  • children
  • Pneumococcal disease
Download:
2020 ∙ Choe, Y. J. Blatt, D. B. Lee, H. J. Choi, E. H.

Associations between geographic region and immune response variations to pneumococcal conjugate vaccines in clinical trials: A systematic review and meta-analysis

  • Newborn
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2020 ∙ Mo, Y. Zeng, J. Xiao, C. Zhang, L. Wang, L. Lu, F. Johnson, D. W. Stålsby Lundborg, C. Nitsch, D. Liu, X. Su, G.

Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2020 ∙ Onwuchekwa, C. Edem, B. Williams, V. Oga, E.

Estimating the impact of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: A systematic review

  • Africa
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ Garrido, H. M. G. Schnyder, J. L. Tanck, M. W. T. Vollaard, A. Spijker, R. Grobusch, M. P. Goorhuis, A.

Immunogenicity of pneumococcal vaccination in HIV infected individuals: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pregnant women
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2020 ∙ Nieto Guevara, J. Borys, D. DeAntonio, R. Guzman-Holst, A. Hoet, B.

Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review

  • Children
  • Newborn
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2020 ∙ de Sévaux, J. L. Venekamp, R. P. Lutje, V. Hak, E. Schilder, A. G. Sanders, E. A. Damoiseaux, R. A.

Pneumococcal conjugate vaccines for preventing acute otitis media in children

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2020 ∙ Zakiyah, N. Insani, W. N. Suwantika, A. A. van der Schans, J. Postma, M. J.

Pneumococcal vaccination for children in Asian countries: A systematic review of economic evaluation studies

  • South-East Asia
  • Western Pacific
  • Children
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
Loading...